Y-79 retinoblastoma cells: isolation and characterization of clonal lineages

M A Campbell1, P Karras, G J Chader

  • 1Toxic Effects Branch, U.S. Environmental Protection Agency, Washington, DC 20460.

Insights

The Y-79 cell line contains at least two distinct cell types, as shown by varied responses to different treatments. These cells exhibit remarkable plasticity, adapting their morphology to various agents.

Area of Science:

  • Retinal cell biology
  • Cancer cell line research
  • Cellular differentiation

Background:

  • Y-79 cells are a retinoblastoma cell line typically undifferentiated.
  • Inducing differentiation in Y-79 cells can lead to various retinal cell phenotypes.
  • Previous studies lacked clarity on whether agents select distinct cell lineages or if cells respond differently.

Purpose of the Study:

  • To investigate the heterogeneity within the parental Y-79 cell line.
  • To determine if different treatment agents select for distinct cell lineages.
  • To assess the differential responsiveness of Y-79 cell subpopulations.

Main Methods:

  • Isolation of 16 clonal lineages from the Y-79 cell line.
  • Characterization of clonal responses to dibutyryl cyclic AMP, butyrate, and laminin.
  • Assessment of cell viability, growth, and attachment frequency under different treatment conditions.

Main Results:

  • Butyrate treatment (1 mM) induced significant mortality (20-84%) in Y-79 cells.
  • Laminin (100 µg/mL) did not inhibit cell growth and sometimes enhanced it.
  • Attachment frequency to laminin-coated substrates varied significantly among clones.
  • Comparative analysis revealed at least two distinct cell types within the parental Y-79 line.
  • No significant differences in morphological changes induced by agents were observed across clones, indicating high cell plasticity.

Conclusions:

  • The Y-79 cell line is heterogeneous, containing at least two distinct cell types.
  • While cell types differ in their response to specific agents, their morphological plasticity is high.
  • This heterogeneity and plasticity are critical considerations for using Y-79 cells in retinoblastoma research.